NCT03619538View on ClinicalTrials.gov

Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Colonic NeoplasmsDiverticulosis, Colonic
Interventions
DRUG

Nefopam

The nefopam group received 120 mg nefopam (Acupan, Pharmbio, France) by continuous iv infusion over the study period (48h)

OTHER

saline solution

The Control group received 120 mg placebo infusion (saline solution) by continuous iv infusion over the study period (48h).

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT03619538 - Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery | Biotech Hunter | Biotech Hunter